Collection's Items (Sorted by Submit Date in Descending order): 1 to 13 of 13
| Issue Date | Title | Author(s) |
| 2024 | Synthesis and pharmacological activity of various organic and inorganic salts of phenyl derivatives of imidazobenzimidazole | Zhukovskaya, O. N.; Eliseeva, N. V.; Vassiliev, P. M.; Pridvorov, G. V.; Grechko, O. Yu. |
| 2024 | Study of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling | Stepenko, Yu. V.; Shmigerova, V. S.; Kostina, D. A.; Shcheblykina, O. V.; Zhernakova, N. I.; Solin, A. V.; Koroleva, N. V.; Markovskaya, V. A.; Dudnikova, O. V.; Bolgov, A. A. |
| 2024 | Approaches to therapy Amlodipine/Indapamide/ Perindopril therapy of high arterial hypertension in ischemic heart disease patients with chronic kidney disease stage 1-3 after coronary stenting | Pribylov, S. A.; Leonidova, K. O.; Pribylov, V. S.; Gavrilyuk, E. V.; Pribylova, N. N. |
| 2024 | Assessment of VEGF and TNF-alpha levels in patients with an unexpectedly poor and suboptimal response during the treatment of infertility using ART methods | Perfilova, V. N.; Muzyko, E. A.; Tikhaeva, K. Yu.; Kustova, M. V.; Mukhina, A. V. |
| 2024 | An effective way for targeting EGFR-mediated carcinogenesis: an in vitro study | Pakina, V. A.; Iksanova, E. Z.; Shikh, E. V.; Tumutolova, O. M.; Arutiunian, K. K. |
| 2024 | Intranasal administration of ghrelin receptor antagonist [D-Lys-3]-GHRP-6 reduces the manifestations of impulsivity and compulsivity induced by maternal deprivation in rats | Pyurveev, S. S.; Lebedev, A. A.; Bychkov, E. R.; Shabanov, P. D. |
| 2024 | Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate | Khokhlov, A. L.; Yaichkov, I. I.; Alexeev, M. A.; Korsakov, M. K.; Shetnev, A. A. |
| 2024 | Implementation of pharmacogenetics for treatment of patients with acute lymphoblastic leukemia | Graiqevci-Uka, V.; Behluli, E.; Hadziselimovic, R.; Liehr, T.; Temaj, G. |
| 2024 | Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3- hydroxypyridinium N-acetyltaurinate in the modeling of POAG | Efimenko, S. V.; Korokin, M. V.; Gudyrev, O. S.; Danilenko, L. M.; Korokina, L. V. |
| 2024 | FIMD based model validation approaches for Rheumatoid arthritis and associated cardiovascular complications: an attempt towards translational competence | Dubey, T.; Patel, K. V. |
| 2024 | Protective effects of thymogen analogues, modified by D-alanine, in hydrazine liver damage | Chulanova, A. A.; Smakhtina, A. M.; Mal, G. S.; Bobyntsev, I. I.; Mishina, E. S. |
| 2024 | Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice | Borozdina, N. A.; Kazakova, E. N.; Gladkikh, I. N.; Leychenko, E. V.; Dyachenko, I. A. |
| 2024 | Development of a transcutaneous form of desloratadine | Ageev, V. P.; Zaborovskiy, A. V.; Yunina, D. V.; Tararina, L. A.; Devkota, M. K. |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 13 of 13
